SAN CARLOS, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel ...

Iovance Biotherapeutics (IOVA) announced that Dan Kirby will join the Company’s executive leadership team in the newly created role of Chief Commercial Officer, effective today. Prior to joining ...

“I would like to extend a warm welcome to Dan Kirby on behalf of the entire Iovance team,” stated Frederick Vogt, Ph.D., J.D., Interim President, Chief Executive Officer and board member of ...

10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating ...

Dan Kirby's appointment as Chief Commercial Officer is significant, as he brings extensive experience in building and leading commercial strategies in the cell therapy sector, which could enhance ...

10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating ...

Iovance Biotherapeutics shares fell 6.41% after appointing Dan Kirby as Chief Commercial Officer, signaling investor concerns. The decline reflects skepticism about the company's growth trajectory ...

Cillian Murphy has been named Best Lead Actor in the film category of the Irish Film and Television Awards (IFTAs) for the ...